145 related articles for article (PubMed ID: 2786431)
21. The interaction of antibody/DNA immune complexes with complement. Influence of antibody class and DNA conformation.
Taylor RP; Edberg JC; Kujala GA; Sloman AJ; Wilson CC; Cronin ME
Arthritis Rheum; 1987 Feb; 30(2):176-85. PubMed ID: 3493781
[TBL] [Abstract][Full Text] [Related]
22. Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus.
Wilson JG; Ratnoff WD; Schur PH; Fearon DT
Arthritis Rheum; 1986 Jun; 29(6):739-47. PubMed ID: 2941021
[TBL] [Abstract][Full Text] [Related]
23. Interaction of complement-solubilized immune complexes with CR1 receptors on human erythrocytes. The binding reaction.
Jepsen HH; Svehag SE; Jarlbaek L; Baatrup G
Scand J Immunol; 1986 Jan; 23(1):65-73. PubMed ID: 2939551
[TBL] [Abstract][Full Text] [Related]
24. Decreased expression of C3b receptor (CR1) on erythrocytes of patients with systemic lupus erythematosus contrasts with its normal expression in other systemic diseases and does not correlate with the occurrence or severity of SLE nephritis.
Jouvin MH; Wilson JG; Bourgeois P; Fearon DT; Kazatchkine MD
Complement; 1986; 3(2):88-96. PubMed ID: 2945697
[TBL] [Abstract][Full Text] [Related]
25. Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus.
Iida K; Mornaghi R; Nussenzweig V
J Exp Med; 1982 May; 155(5):1427-38. PubMed ID: 6978375
[TBL] [Abstract][Full Text] [Related]
26. Immune complexes bind preferentially to specific subpopulations of human erythrocytes.
Cosio FG; Shen XP; Hebert LA
Clin Immunol Immunopathol; 1990 Jun; 55(3):337-54. PubMed ID: 2140304
[TBL] [Abstract][Full Text] [Related]
27. Immune adherence and clearance of hepatitis B surface Ag/Ab complexes is abnormal in patients with systemic lupus erythematosus (SLE).
Madi N; Steiger G; Estreicher J; Schifferli JA
Clin Exp Immunol; 1991 Sep; 85(3):373-8. PubMed ID: 1893616
[TBL] [Abstract][Full Text] [Related]
28. Concerted clearance of immune complexes bound to the human erythrocyte complement receptor: development of a heterologous mouse model.
Henderson AL; Lindorfer MA; Kennedy AD; Foley PL; Taylor RP
J Immunol Methods; 2002 Dec; 270(2):183-97. PubMed ID: 12379324
[TBL] [Abstract][Full Text] [Related]
29. A kinetic study of factor I-mediated modification and release of RBC-bound DNA-anti-DNA immune complexes.
Meryhew NL; Mukherjee J; Creager MS; Runquist OA
J Lab Clin Med; 1992 Jul; 120(1):111-9. PubMed ID: 1613317
[TBL] [Abstract][Full Text] [Related]
30. CR1 polymorphism in hydralazine-induced systemic lupus erythematosus: DNA restriction fragment length polymorphism.
Mitchell JA; Sim RB; Sim E
Clin Exp Immunol; 1989 Dec; 78(3):354-8. PubMed ID: 2575471
[TBL] [Abstract][Full Text] [Related]
31. Mononuclear phagocyte system in SLE. II. A kinetic model of immune complex handling in systemic lupus erythematosus.
Meryhew NL; Kimberly RP; Messner RP; Runquist OA
J Immunol; 1986 Jul; 137(1):97-102. PubMed ID: 3486919
[TBL] [Abstract][Full Text] [Related]
32. The complement-mediated binding of soluble antibody/dsDNA immune complexes to human neutrophils.
Taylor RP; Burge J; Horgan C; Shasby DM
J Immunol; 1983 Jun; 130(6):2656-62. PubMed ID: 6854016
[TBL] [Abstract][Full Text] [Related]
33. Low number of complement C3b/C4b receptors (CR1) on erythrocytes from patients with essential mixed cryoglobulinemia, systemic lupus erythematosus and rheumatoid arthritis: relationship with disease activity, anticardiolipin antibodies, complement activation and therapy.
Corvetta A; Pomponio G; Bencivenga R; Luchetti MM; Spycher M; Spaeth PJ; Danieli G
J Rheumatol; 1991 Jul; 18(7):1021-5. PubMed ID: 1833542
[TBL] [Abstract][Full Text] [Related]
34. Competition for immune complexes by red cells in human blood.
Medof ME; Oger JJ
J Clin Lab Immunol; 1982 Jan; 7(1):7-13. PubMed ID: 7069779
[TBL] [Abstract][Full Text] [Related]
35. Immune complexes and erythrocyte CR1 (complement receptor type 1): effect of CR1 numbers on binding and release reactions.
Ng YC; Schifferli JA; Walport MJ
Clin Exp Immunol; 1988 Mar; 71(3):481-5. PubMed ID: 2968204
[TBL] [Abstract][Full Text] [Related]
36. CR1 deficiency in SLE: acquired or genetic?
Uko G; Dawkins RL; Kay P; Christiansen FT; Hollingsworth PN
Clin Exp Immunol; 1985 Nov; 62(2):329-36. PubMed ID: 2935336
[TBL] [Abstract][Full Text] [Related]
37. Relationship between immune complex binding and release and the quantitative expression of the complement receptor, type 1 (CR1, CD35) on human erythrocytes.
Gibson NC; Waxman FJ
Clin Immunol Immunopathol; 1994 Feb; 70(2):104-13. PubMed ID: 8299225
[TBL] [Abstract][Full Text] [Related]
38. Low C3b receptor reactivity on erythrocytes from patients with systemic lupus erythematosus detected by immune adherence hemagglutination and radioimmunoassays with monoclonal antibody.
Minota S; Terai C; Nojima Y; Takano K; Takai E; Miyakawa Y; Takaku F
Arthritis Rheum; 1984 Dec; 27(12):1329-35. PubMed ID: 6239627
[TBL] [Abstract][Full Text] [Related]
39. Immune complex binding efficiency of erythrocyte complement receptor 1 (CR1).
Madi N; Paccaud JP; Steiger G; Schifferli JA
Clin Exp Immunol; 1991 Apr; 84(1):9-15. PubMed ID: 1826650
[TBL] [Abstract][Full Text] [Related]
40. Difference in the clustering of complement receptor type 1 (CR1) on polymorphonuclear leukocytes and erythrocytes: effect on immune adherence.
Paccaud JP; Carpentier JL; Schifferli JA
Eur J Immunol; 1990 Feb; 20(2):283-9. PubMed ID: 2138082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
